C07H 19/213
Containing cyclic phosphate
Official title: containing cyclic phosphate
C07H19/213 (Containing cyclic phosphate) appears on 92 US grants and 130 published applications in this corpus.
Search patents in C07H- Granted patents
- 92
- Published applications
- 130
- Assignees
- 68
- Inventors
- 279
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 2 | 2 |
| 2012 | 1 | 6 |
| 2013 | 5 | 4 |
| 2014 | 3 | 16 |
| 2015 | 6 | 6 |
| 2016 | 9 | 10 |
| 2017 | 9 | 12 |
| 2018 | 8 | 7 |
| 2019 | 12 | 19 |
| 2020 | 7 | 10 |
| 2021 | 7 | 11 |
| 2022 | 6 | 8 |
| 2023 | 7 | 7 |
| 2024 | 3 | 6 |
| 2025 | 4 | 1 |
| 2026 | 3 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Nucleoside analogs and use thereof in therapeutic treatment4 Aug 2026US 12,698,305 B2Cornell University
- Equatorially modified polymer linked multimers of guansine-3′, 5′-cyclic monophosphates24 Mar 2026US 12,583,882 B2Mireca Medicines GmbH
- Asymmetric auxiliary group24 Mar 2026US 12,583,883 B2Wave Life Sciences Ltd.
- Polymer linked multimers of guanosine-3′, 5′-cyclic monophosphates12 Aug 2025US 12,384,813 B2Mireca Medicines GmbH
- Chiral phosphoramidite auxiliaries and methods of their use8 Apr 2025US 12,269,839 B2Sirius Therapeutics, Inc.
- Cyclic phosphoramidate compounds12 Jun 2025US 2025/0188111 A1
- 4-ethynyl-3-hydroxy-tetrahydrofuranyl-adenine phosphoramidates and related compounds and their use in treating medical conditions7 Nov 2024US 2024/0366649 A1ROME Therapeutics, Inc.
- Improved methods for production of cyclic guanosine-monophosphate analogues24 Oct 2024US 2024/0352056 A1Mireca Medicines GmbH
- Cyclic dinucleotide metal compound, and preparation and application thereof26 Sep 2024US 2024/0317792 A1Hangzhou Xingao Biotechnology Co., Ltd
- 3'3' cyclic dinucleotides containing isonucleotidic units23 May 2024US 2024/0166681 A1Institute of Organic Chemistry and Biochemistry AS Cr, V. V. I.
Most cited
By later US patents
- Substituted nucleosides, nucleotides and analogs thereof72US 9,249,174 B2Alios BioPharma, Inc. · 2016
- 2′-chloroacetylenyl substituted nucleoside derivatives67US 8,575,119 B2Enanta Pharmaceuticals, Inc. · 2013
- 4′-fluoro nucleosides for the treatment of HCV63US 9,211,300 B2Centre National De La Recherche Scientifique · 2015
- Synthesis of purine nucleosides62US 8,716,263 B2Gilead Pharmasset LLC · 2014
- Cyclic nucleotide analogs61US 8,772,474 B2Alios BioPharma, Inc. · 2014